179.20
179.20 (0%)
As of Dec 26, 2024
AbbVie Inc [ABBV]
Source:
Company Overview
AbbVie is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, oncology, aesthetics, neuroscience and eye care.
| Country | United States |
| Headquarters | north chicago, illinois |
| Phone Number | (847) 932-7900 |
| Industry | manufacturing |
| CEO | Robert A. Michael |
| Website | www.abbvie.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $56,334 |
| Operating Profit | $9,137 |
| Net Income | $4,286 |
| Net Cash | $-7,290 |
Profit Ratios
| Gross Margin | $39,430 |
| Operating Margin | 16.2 |
| Profit as % of Revenues | 920% |
| Profit as % of Assets | 3.2% |
| Profit as % of Stockholder Equity | 127.4% |
Management Effectiveness
| Return on Equity | 127.4% |
| Return on Assets | 3.2% |
| Turnover Ratio | 41.8% |
| EBITA | $9,137 |
Balance Sheet and Cash Flow Measures
| Total Assets | $135,161 |
| Total Liabilities | $131,797 |
| Operating Cash Flow | $18,806 |
| Investing Cash Flow | $-20,820 |
| Financing Cash Flow | $-5,211 |
